Cargando…

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma

SIMPLE SUMMARY: We systematically reviewed the recent scientific publications describing the role of microRNAs in the regulation of drug resistance in colon cancer. To clarify the intricate web of resulting genetic and biochemical interactions, we used a machine learning approach aimed at creating:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crudele, Francesca, Bianchi, Nicoletta, Astolfi, Annalisa, Grassilli, Silvia, Brugnoli, Federica, Terrazzan, Anna, Bertagnolo, Valeria, Negrini, Massimo, Frassoldati, Antonio, Volinia, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431668/ https://www.ncbi.nlm.nih.gov/pubmed/34503164 http://dx.doi.org/10.3390/cancers13174355

Ejemplares similares

A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K(+) Channel in Breast Cancer
por: Canella, Rita, et al.
Publicado: (2022)

Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
por: Terrazzan, Anna, et al.
Publicado: (2023)

The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
por: Bianchi, Nicoletta, et al.
Publicado: (2021)

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
por: Corrà, Fabio, et al.
Publicado: (2021)

Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype
por: Grassilli, Silvia, et al.
Publicado: (2022)

Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
por: Grassilli, Silvia, et al.
Publicado: (2022)

Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways
por: Crudele, Francesca, et al.
Publicado: (2023)

Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer
por: Grassilli, Silvia, et al.
Publicado: (2020)

CD133 in Breast Cancer Cells: More than a Stem Cell Marker
por: Brugnoli, Federica, et al.
Publicado: (2019)

The network of non-coding RNAs and their molecular targets in breast cancer
por: Crudele, Francesca, et al.
Publicado: (2020)

Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
por: Al-Qassab, Yasamin, et al.
Publicado: (2018)

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133(+)/EpCAM(+) phenotype: a promising target for preventing progression of TNBC
por: Brugnoli, Federica, et al.
Publicado: (2017)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA)
por: Brugnoli, Federica, et al.
Publicado: (2020)

Ectopic expression of PLC‐β2 in non‐invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR‐146a
por: Bertagnolo, Valeria, et al.
Publicado: (2019)

Unexpected findings of variability in microRNAs suggest roles in human genetics
por: Volinia, Stefano
Publicado: (2012)

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome
por: Grassilli, Silvia, et al.
Publicado: (2018)

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
por: Aguiari, Gianluca, et al.
Publicado: (2022)

Vav1 is necessary for PU.1 mediated upmodulation of miR‐29b in acute myeloid leukaemia‐derived cells
por: Vezzali, Federica, et al.
Publicado: (2018)

Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease
por: Bianchi, Nicoletta, et al.
Publicado: (2022)

Absolute quantification of cell-free microRNAs in cancer patients
por: Ferracin, Manuela, et al.
Publicado: (2015)

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells
por: Volinia, Stefano, et al.
Publicado: (2018)

Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells
por: Bergamini, Carlo M., et al.
Publicado: (2021)

The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO
por: Tedeschi, Paola, et al.
Publicado: (2023)

MicroRNAs in Animal Models of HCC
por: Fornari, Francesca, et al.
Publicado: (2019)

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
por: Mangolini, Alessandra, et al.
Publicado: (2015)

High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process
por: Grassilli, Silvia, et al.
Publicado: (2014)

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
por: Roncarati, Roberta, et al.
Publicado: (2019)

Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells
por: Almanza, Gonzalo, et al.
Publicado: (2010)

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
por: Lanzaro, Francesca, et al.
Publicado: (2023)

MicroRNAs as Biomarkers in Thyroid Carcinoma
por: Celano, Marilena, et al.
Publicado: (2017)

Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
por: Ogata-Kawata, Hiroko, et al.
Publicado: (2014)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

MicroRNA Profiles Discriminate among Colon Cancer Metastasis
por: Drusco, Alessandra, et al.
Publicado: (2014)

Identification of microRNA activity by Targets' Reverse EXpression
por: Volinia, Stefano, et al.
Publicado: (2010)

Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response
por: Aquino, Angelo, et al.
Publicado: (2023)

Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening
por: Kunte, Dhananjay P., et al.
Publicado: (2012)

MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer
por: Wang, Jian, et al.
Publicado: (2015)

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7fl9ffq45jnm0l9ic5sg1qrs7q